Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 14/20 | 0.60 |
| ▸ | PLA2R1 | Q13018 | 1/20 | 0.60 |
| ▸ | DHODH | Q02127 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3716275 | 1.00 | PTPN1 (0.60) | PTPN1PLA2R1DHODH | |
| SCHEMBL13028176 | 1.00 | PTPN1 (0.60) | PTPN1PLA2R1DHODH | |
| SCHEMBL2893191 | 1.00 | PTPN1 (0.60) | PTPN1PLA2R1DHODH | |
| SCHEMBL2885029 | 1.00 | PTPN1 (0.60) | PTPN1PLA2R1DHODH | |
| SCHEMBL2888923 | 1.00 | PTPN1 (0.60) | PTPN1PLA2R1DHODH | |
| SCHEMBL2890781 | 1.00 | PTPN1 (0.60) | PTPN1PLA2R1DHODH | |
| SCHEMBL13028178 | 1.00 | PTPN1 (0.60) | PTPN1PLA2R1DHODH | |
| Macrocarpal I SCHEMBL29756964 | 0.76 | PTPN1 (0.43) | PTPN1PLA2R1DHODH | |
| Macrocarpal I SCHEMBL134874 | 0.76 | PTPN1 (0.43) | PTPN1PLA2R1DHODH | |
| Macrocarpal J SCHEMBL96425 | 0.76 | PTPN1 (0.43) | PTPN1PLA2R1DHODH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119157930-A | Application of eucalyptus fruit extract in preparation of medicines or products for preventing and treating liver lipid metabolism abnormality related diseases | 中国药科大学 | 2024-12-20 | — | — | CN | claimed |
| US-20100286284-A1 | 5-[1'-(DECAHYDRO-7-HYDROXY-1,1,3A,7-TETRAMETHYL-1H-CYCLOPROPA[A]NAPHTHALEN-4-YL)-3'-METHYLBUTYL]-2,4,6-TRIHYDROXY-1,3-BENZENEDICARBOXALDEHYDE AS MEDICAMENTS | PIERRE FABRE MEDICAMENT (FR) | 2010-11-11 | — | — | US | claimed |
| CN-119280201-A | Application of formylparanol mixed source terpenoid derivatives or pharmaceutically acceptable salts thereof in preparation of medicines for preventing and treating liver lipid metabolism abnormality related diseases | 中国药科大学 | 2025-01-10 | — | — | CN | disclosed |
| CN-119157930-A | Application of eucalyptus fruit extract in preparation of medicines or products for preventing and treating liver lipid metabolism abnormality related diseases | 中国药科大学 | 2024-12-20 | — | — | CN | disclosed |
| US-20100286284-A1 | 5-[1'-(DECAHYDRO-7-HYDROXY-1,1,3A,7-TETRAMETHYL-1H-CYCLOPROPA[A]NAPHTHALEN-4-YL)-3'-METHYLBUTYL]-2,4,6-TRIHYDROXY-1,3-BENZENEDICARBOXALDEHYDE AS MEDICAMENTS | PIERRE FABRE MEDICAMENT (FR) | 2010-11-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100286284-A1 | 5-[1'-(DECAHYDRO-7-HYDROXY-1,1,3A,7-TETRAMETHYL-1H-CYCLOPROPA[A]NAPHTHALEN-4-YL)-3'-METHYLBUTYL]-2,4,6-TRIHYDROXY-1,3-BENZENEDICARBOXALDEHYDE AS MEDICAMENTS | TPH1, DBH, TPH2 | PTPN1 2332/4885PLA2R1 2604/4885DHODH 289/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.